Published in
Elsevier, Journal of the Neurological Sciences, (372), p. 92-96
DOI: 10.1016/j.jns.2016.11.016
Links
Tools
Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up
Journal article published in 2017 by
M. E. Evangelopoulos 
,
E. Andreadou,
G. Koutsis,
V. Koutoulidis,
M. Anagnostouli,
P. Katsika,
D. S. Evangelopoulos,
I. Evdokimidis,
C. Kilidireas
,
E. Andreadou,
G. Koutsis,
V. Koutoulidis,
M. Anagnostouli,
P. Katsika,
D. S. Evangelopoulos,
I. Evdokimidis,
C. Kilidireas
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 